Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. Scholle MD, O'Kane PT, Dib S, Gurard-Levin ZA, et al. Antiviral Res 2022;200:105279.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Scholle MD, O'Kane PT, Dib S, Gurard-Levin ZA, et al. Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. Antiviral Res 2022;200:105279.
PMID: 35278580